PDCD1 and tuberculosis: In mouse and rhesus macaque models, anti-PD-1 therapy exacerbated TB, increasing bacterial loads and pro-inflammatory cytokine production (e.g., IFN-γ, TNF) by Mtb-specific CD8+ T cells.